Delivery Order SPE2DB24D2213-SPE2DB25FGWPD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,722.28 to AmerisourceBergen Drug Corp for Diflucan 200 mg tablets (20-count packages) with a firm fixed price structure. This non-competitive delivery order, issued on July 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Diflucan 200 mg tablets (20-count packaging) with a ceiling value of $26,974.44. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion on July 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Diflucan 200 mg tablets (20-count units) with a ceiling value of $17,723.23. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 13, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $32,948.63 to AmerisourceBergen Drug Corp for the supply of Diflucan (Fluconazole) 200 mg tablets in quantities of 20 units. This firm fixed price delivery order, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitively awarded, non-set-aside contract. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $51,645.52 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Diflucan (fluconazole) 200 mg tablets in quantities of 20 per unit. This competitive award, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract utilizes firm fixed pricing and requires...
- The Defense Logistics Agency awarded a delivery order valued at $26,207.54 to AmerisourceBergen Drug Corp for Diflucan (fluconazole) 200 mg tablets in quantities of 20 on August 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $10,920.67 to AmerisourceBergen Drug Corp for Diflucan 200 mg tablets (20-count packages). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diflucan (fluconazole) 200 mg tablets in a quantity of 20 units, valued at $33,203.28. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by July 31, 2025. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $45,757.32 by the Defense Logistics Agency (DLA) for 200 mg Diflucan tablets in quantities of 20. The contract, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Diflucan (fluconazole) 200 mg tablets in quantities of 20 per package, with a ceiling value of $23,255.43. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by September 4, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania, leveraging its established...
- SPE2DB24D2213Indefinite Delivery Contract
- SPE2DB24D2213-SPE2DB25FGWPDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20 tablets of Diflucan 200 mg medication on April 30, 2025, with a ceiling value of $18,991.42 and firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by May 1, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government, supporting military and veteran healthcare needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract awards demonstrate its capability to fulfill diverse military healthcare requirements through open and competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 4/30/25 |